EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Diagnostic Significance of hsa-miR-21-5p, hsa-miR-192-5p, hsa-miR-155-5p, hsa-miR-199a-5p Panel and Ratios in Hepatocellular Carcinoma on Top of Liver Cirrhosis in HCV-Infected Patients

Mona A Eldosoky, Reham Hammad iD, Asmaa A Elmadbouly iD, Reda Badr Aglan iD, Sherihan G Abdel-Hamid iD, Mohamed Alboraie iD, Donia Ahmed Hassan, Mohamed A Shaheen, Areej Rushdi iD, Reem M Ahmed, Alzahra Abdelbadea, Neamat A Abdelmageed und 6 weitere

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24043157 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Mona A Eldosoky und 17 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Pathology Department, Faculty of Medicine (for Girls), Al-Azhar University, Nasr City 11884, Egypt. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Hepatitis C, Chronic, MicroRNAs. Die Arbeit wurde bisher 72-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: self-financed.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Early hepatocellular carcinoma (HCC) diagnosis is challenging. Moreover, for patients with alpha-fetoprotein (AFP)-negative HCC, this challenge is augmented. MicroRNAs (miRs) profiles may serve as potential HCC molecular markers. We aimed to assess plasma homo sapiens—(hsa)-miR-21-5p, hsa-miR-155-5p, hsa-miR-192-5p, and hsa-miR-199a-5p—expression levels as a panel of biomarkers for HCC in chronic hepatitis C virus (CHCV) patients with liver cirrhosis (LC), especially AFP-negative HCC cases, as a step toward non-protein coding (nc) RNA precision medicine. Subjects and methods: 79 patients enrolled with CHCV infection with LC, subclassified into an LC group without HCC (n = 40) and LC with HCC (n = 39). Real-time quantitative PCR was used to measure plasma hsa-miR-21-5p, hsa-miR-155-5p, hsa-miR-192-5p, and hsa-miR-199a-5p.

Results

Plasma hsa-miR-21-5p and hsa-miR-155-5p demonstrated significant upregulation, while hsa-miR-199a-5p demonstrated significant downregulation in the HCC group (n = 39) when compared to the LC group (n = 40). hsa-miR-21-5p expression was positively correlated with serum AFP, insulin, and insulin resistance (r = 0.5, p < 0.001, r = 0.334, p = 0.01, and r = 0.303, p = 0.02, respectively). According to the ROC curves, for differentiating HCC from LC, combining AFP with each of hsa-miR-21-5p, hsa-miR-155-5p, and miR199a-5p improved the diagnostic sensitivity to 87%, 82%, and 84%, respectively, vs. 69% for AFP alone, with acceptable specificities of 77.5%, 77.5%, and 80%, respectively, and AUC = 0.89, 0.85, and 0.90, respectively vs. 0.85 for AFP alone. hsa-miR-21-5p/hsa-miR-199a-5p and hsa-miR-155-5p/hsa-miR-199a-5p ratios discriminated HCC from LC at AUC = 0.76 and 0.71, respectively, with sensitivities = 94% and 92% and specificities = 48% and 53%, respectively. Upregulation of plasma hsa-miR-21-5p was considered as an independent risk factor for HCC development [OR = 1.198(1.063–1.329), p = 0.002].

Conclusions

Combining each of hsa-miR-21-5p, hsa-miR-155-5p, and hsa-miR-199a-5p with AFP made it possible to identify HCC development in the LC patients’ cohort with higher sensitivity than using AFP alone. hsa-miR-21-5p/hsa-miR-199a-5p and hsa-miR-155-5p/hsa-miR-199a-5p ratios are potential HCC molecular markers for AFP-negative HCC patients. hsa-miR-21-5p was linked, clinically and via in silico proof, to insulin metabolism, inflammation, dyslipidemia, and tumorigenesis in the HCC patients’ group as well as for an upregulated independent risk factor for the emergence of HCC from LC in the CHCV patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsHepatitis C, ChronicMicroRNAsInsulinsHumansalpha-FetoproteinsBiomarkers, TumorLiver Cirrhosis

Stichwörter der Autor:innen

AFP-negative HCCHCCHCVbioinformatics/in silico analysishsa-miR-155-5phsa-miR-192-5phsa-miR-199a-5phsa-miR-21-5pliver cirrhosis

Substanzen

MIRN192 microRNA, humanalpha-FetoproteinsBiomarkers, TumorMicroRNAsInsulinsMIRN155 microRNA, humanMIRN21 microRNA, human

Autor:innen und Institutionen

  • Clinical Pathology Department, Faculty of Medicine (for Girls), Al-Azhar University, Nasr City 11884, Egypt.
  • Hepatology and Gastroenterology Department, National Liver Institute, Menoufia University, Shibin El-Kom 32514, Egypt.
  • Biochemistry Department, Faculty of Pharmacy, Ain Shams University, Cairo 11566, Egypt.
  • Department of Internal Medicine, Al-Azhar University, Cairo 11884, Egypt.
  • Clinical Pathology Department, Faculty of Medicine (for Boys), Al-Azhar University, Cairo 11884, Egypt.
  • Microbiology and Immunology Department, Faculty of Medicine for Girls, Al-Azhar University, Cairo 11884, Egypt.

ORCID-Profile: Reham Hammad, Asmaa A Elmadbouly, Reda Badr Aglan, Sherihan G Abdel-Hamid, Mohamed Alboraie, Areej Rushdi, Ahmed Elshafei, Nadia M Hamdy

Förderung

  • self-financed

Zitieren

APA

Eldosoky, M. A., Hammad, R., Elmadbouly, A. A., Aglan, R. B., Abdel-Hamid, S. G., Alboraie, M., Hassan, D. A., Shaheen, M. A., Rushdi, A., Ahmed, R. M., Abdelbadea, A., Abdelmageed, N. A., Elshafei, A., Ali, E., Abo-Elkheir, O. I., Zaky, S., Hamdy, N. M., & Lambert, C. (2023). Diagnostic Significance of hsa-miR-21-5p, hsa-miR-192-5p, hsa-miR-155-5p, hsa-miR-199a-5p Panel and Ratios in Hepatocellular Carcinoma on Top of Liver Cirrhosis in HCV-Infected Patients. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24043157

Vancouver

Eldosoky MA, Hammad R, Elmadbouly AA, Aglan RB, Abdel-Hamid SG, Alboraie M, et al. Diagnostic Significance of hsa-miR-21-5p, hsa-miR-192-5p, hsa-miR-155-5p, hsa-miR-199a-5p Panel and Ratios in Hepatocellular Carcinoma on Top of Liver Cirrhosis in HCV-Infected Patients. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24043157

BibTeX
@article{Eldosoky2023,
  author = {Eldosoky, Mona A and Hammad, Reham and Elmadbouly, Asmaa A and Aglan, Reda Badr and Abdel-Hamid, Sherihan G and Alboraie, Mohamed and Hassan, Donia Ahmed and Shaheen, Mohamed A and Rushdi, Areej and Ahmed, Reem M and Abdelbadea, Alzahra and Abdelmageed, Neamat A and Elshafei, Ahmed and Ali, Elham and Abo-Elkheir, Omaima I and Zaky, Samy and Hamdy, Nadia M and Lambert, Claude},
  title = {Diagnostic Significance of hsa-miR-21-5p, hsa-miR-192-5p, hsa-miR-155-5p, hsa-miR-199a-5p Panel and Ratios in Hepatocellular Carcinoma on Top of Liver Cirrhosis in HCV-Infected Patients},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24043157}
}
Kostenlos starten →